Found: 3
Select item for more details and to access through your institution.
Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on Neutrophil-Lymphocyte Ratio Fluctuation and Liver Metastases.
- Published in:
- Oncology, 2024, v. 102, n. 6, p. 457, doi. 10.1159/000534554
- By:
- Publication type:
- Article
C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 4, p. 635, doi. 10.1007/s11523-024-01068-7
- By:
- Publication type:
- Article
Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 3, p. 401, doi. 10.1007/s11523-024-01047-y
- By:
- Publication type:
- Article